Drug Safety Settlement
Daiichi Sankyo says it was misled over Ranbaxy U.S. probes
Japanese drugmaker Daiichi Sankyo Co, which bought control of Ranbaxy Laboratories in 2008, said it believes unnamed former shareholders of the company hid information regarding U.S. regulatory probes into Ranbaxy. Full Article
REUTERS SHOWCASE
Buy, Sell or Hold?
Confused while buying stocks? Get buy, sell or hold recommendations from VantageTrade. Full Coverage
Reuters India Mobile
Get the latest news on the go. Visit Reuters India on your mobile device. Full Coverage
Anti-counterfeiting agreement signed in Tokyo
Track Markets: BSE Sectoral Indices
Track and analyse performance of all BSE sectoral indices and other global indices on a single page. Full Coverage
TOKYO |
TOKYO (Reuters) - Governments of eight nations including Japan and the United Stated signed an agreement on Saturday, aiming to cut costly copyright and trademark theft.
The signing by the eight is a step towards bringing into effect the Anti-Counterfeiting Trade Agreement (ACTA), which is designed to strengthen the legal framework for intellectual property rights, said Japan's Ministry of Economy, Trade and Industry (METI).
The signing took place a year after the final round of negotiations among 11 parties -- Australia, Canada, the European Union, Japan, the Republic of Korea, Mexico, Morocco, New Zealand, Singapore, Switzerland and the United States.
The EU, Mexico and Switzerland have not signed the agreement but have until May 1, 2013, to do so, according to the METI.
The pact takes effect with the ratification of six parties and the METI expects an expansion of ACTA participants.
(Reporting by Kaori Kaneko; Editing by Robert Birsel)
- Tweet this
- Link this
- Share this
- Digg this
- Reprints
Follow Reuters